Have a personal or library account? Click to login
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells Cover

Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells

Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
By: Tanja Mesti,  Nadia Bouchemal,  Claire Banissi,  Mohamed N. Triba,  Carole Marbeuf-Gueye,  Maja Cemazar,  Laurence Le Moyec,  Antoine F. Carpentier,  Philippe Savarin and  Janja Ocvirk  
Open Access
|Nov 2018

Authors

Tanja Mesti

Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou, paris, France
Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Nadia Bouchemal

CSPBAT, UMR 7244, CNRS, Université Paris 13, Bobigny, France

Claire Banissi

Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou, paris, France

Mohamed N. Triba

CSPBAT, UMR 7244, CNRS, Université Paris 13, Bobigny, France

Carole Marbeuf-Gueye

CSPBAT, UMR 7244, CNRS, Université Paris 13, Bobigny, France

Maja Cemazar

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Laurence Le Moyec

Unité de Biologie Intégrative des Adaptations à l’Exercice, Université d’Evry, Evry, France

Antoine F. Carpentier

Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou, paris, France
Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Service de Neurologie, Bobigny, France

Philippe Savarin

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Janja Ocvirk

jocvirk@onko-i.si

Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2018-0046 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 392 - 398
Submitted on: Nov 30, 2017
|
Accepted on: Oct 21, 2018
|
Published on: Nov 26, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
idh1 mutation,
malignant glioma,
bevacizumab,
metabolic,
fingerprint
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Tanja Mesti, Nadia Bouchemal, Claire Banissi, Mohamed N. Triba, Carole Marbeuf-Gueye, Maja Cemazar, Laurence Le Moyec, Antoine F. Carpentier, Philippe Savarin, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 4 (December 2018)Next article